Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May:197:3-12.
doi: 10.1016/j.chemphyslip.2015.08.018. Epub 2015 Sep 3.

Recent progress in the discovery and development of stearoyl CoA desaturase inhibitors

Affiliations
Review

Recent progress in the discovery and development of stearoyl CoA desaturase inhibitors

Yoshikazu Uto. Chem Phys Lipids. 2016 May.

Abstract

Stearoyl-CoA desaturase 1 (SCD1) is a rate-limiting enzyme in the biosynthesis of monounsaturated fatty acids from their saturated fatty acid precursors. SCD1 introduces a cis-double bond at the Δ9 position (between carbons 9 and 10) of stearoyl (C18:0) and palmitoyl-CoA (C16:0). SCD1 has been shown to be a crucial factor in lipid metabolism and body weight control. In addition, SCD1 inhibitors are claimed to be new treatments for various diseases, such as skin disorders, nonalcoholic steatohepatitis (NASH), hepatitis C virus (HCV), Alzheimer's disease, or cancer. This review aims to summarize the examples of the recently reported novel SCD1 inhibitors and to highlight the emerging areas of target indications that may hold promise for the development of SCD1 inhibitors.

Keywords: Acne; Cancer; Nonalcoholic steatohepatitis (NASH); Skin disorders; Stearoyl-CoA desaturase 1 (SCD1).

PubMed Disclaimer

Similar articles

Cited by

LinkOut - more resources